Response of rams to electroejaculation following the administration of oxytocin and cloprostenol with or without GnRH.

The present study aims to evaluate the effect of administering prostaglandin (250 µg cloprostenol) and oxytocin (10 UI) or a GnRH agonist (4.2 µg buserelin acetate) on rams' physiological responses to electroejaculation and the ejaculate's characteristics. The study was performed with a 2 × 2 factorial arrangement, according to whether it used oxytocin and prostaglandin (OXPGF) or GnRH. Therefore, there were four treatments: GControl = saline; GOXPGF = administration of PGF2α and oxytocin; GGnRH = administration of GnRH; administration of GOXPGF + GnRH = GnRH and PGF2α + oxytocin. An interaction between the hormonal treatments in the heart rate occurred: while the heart rate decreased when using OXPGF alone (control: 113.7 bpm vs. GOXPGF: 103.5 bpm, pooled SEM; P = 0.02), it did not modify when applying both treatments simultaneously and administering GnRH (GGnRH: 109.1 bpm vs. GOXPGF + GnRH: 111.5 bpm respectively, pooled SEM = 4.5). The respiratory rate also decreased with the administration of OXPGF (38.7 vs. 46.3 with and without OXPGF, pooled SEM = 10.0, P = 0.003). Administering OXPGF also tended to decrease the temperature (38.77 °C vs. 38.94 °C, with and without OXPGF, respectively, pooled SEM = 0.06; P = 0.056). Blood glucose increased with the administration of OXPGF from 58.7 mg/dL to 62.4 mg/dL (pooled SEM = 1.3, P = 0.014) and varied with time. CK concentrations increased from 641.8 mg/dL to 881.7 mg/dL (pooled SEM = 50.6) with the administration of OXPGF. GnRH administration decreased cortisol concentration from 7.3 ng/mL to 2.1 ng/mL (pooled SEM = 1.4; P = 0.04). The treatments had no effects on the time required for EE, the pulse at which the animals began and ended the ejaculation, or the vocalizations emitted during EE. There were no effects in any evaluated sperm variable. The research concluded that the administration of oxytocin and analogs of PGF2alpha decreased the stress response to electroejaculation, as well as administering GnRH agonist was slightly effective as it only decreased cortisol concentration. Also, these treatments, either alone or combined, did not affect the characteristics of the ejaculate collected.

Bovine oviductal fluid (bOF) collected in the follicular or luteal phase of the estrous cycle exerts similar effects on ram sperm kinematics and acrosome reactivity in vitro.

This study examined the effects of bovine oviductal fluid (bOF) obtained during the follicular or luteal phase of the estrous cycle on ram sperm kinematics, capacitation status and plasma membrane (PM) integrity at various time points during the 24-h incubation period. Fresh ram spermatozoa were selected using the swim-up technique and then incubated separately with either follicular phase (FbOF) or luteal phase (LbOF) bovine oviductal fluid added to Fert-TALP medium (positive control - POSControl) or in Fert-TALP medium without capacitating agents (negative control - NEGControl) at 38 °C under 5% CO2. Incubation with FbOF or LbOF for 2 h and 4 h promoted an increase (P <  0.05) in most of the sperm motility parameters as compared with the NEGControl group, and bOF-induced changes in sperm kinematics were similar (P >  0.05) to those seen in the POSControl group. After 6 h of incubation, the stimulatory effect of FbOF or LbOF on ram sperm kinematics was no longer observed (P >  0.05). Sperm PM integrity was not affected (P >  0.05) by incubation in bOF-supplemented media or in absence of capacitating factors (NEGControl). Although neither FbOF nor LbOF had any effect on sperm capacitation rates, the proportion of acrosome-reacted spermatozoa was greater (P < 0.05) for bOF-containing media compared with the NEGControl group during the long incubation periods (18 h and 24 h). In conclusion, bOF from either follicular or luteal phase of the estrous cycle enhances ram sperm motility for up to 4 h and the rate of acrosome reaction after long (18-24 h) incubation periods without affecting sperm viability.

Cervical transposition test using Hegar dilator at oestrus as a tool to select ewes for transcervical embryo collection.

This study evaluated the cervical transposition method as a tool to select ewes for embryo collection by transcervical route. Adult Santa Inês ewes (n = 50) received Day 0 protocol for superovulation treatments. The cervix transposition test was performed both at oestrus and at the embryo collection time. The latter was preceded by hormonal cervical dilation. The sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 85.7%, 66.6%, 85.7%, 66.6% and 80.0%, respectively. The kappa index yielded a moderate score (κ = 0.52). In conclusion, the high sensitivity and accuracy indicate that the cervical transposition test is a screening option to select ewes for embryo collection by transcervical route.